Vol. 39 No. 1 (2022): FEBRERO
Review Article

Neutropenic enterocolitis in the pediatric cancer patient

Jorge Elias Kassisse Limongi
Hospital Clínico San Borja Arriarán
Bio
Luis Delpiano Mendez
Hospital Clínico San Borja Arriarán
Bio
Francia López Diaz
Hospital Clínico San Borja Arriarán
Bio
Anibal Espinoza Gamboa
Hospital clínico San Borja Arriarán
Bio

Published 2022-03-23

How to Cite

1.
Kassisse Limongi JE, Delpiano Mendez L, López Diaz F, Espinoza Gamboa A. Neutropenic enterocolitis in the pediatric cancer patient. Rev. Chilena. Infectol. [Internet]. 2022 Mar. 23 [cited 2025 Nov. 25];39(1). Available from: https://revinf.cl/index.php/revinf/article/view/1363

Abstract

Neutropenic enterocolitis (NEC) is a heterogeneous disease of the gastrointestinal tract with systemic response, that corresponds to a severe and life-threatening clinical condition in immunocompromised patients, especially in childhood cancer. The pathologic features are poorly understood, although its multifactorial cause of NEC is well established and it is associated with the cytotoxic effects of the chemotherapy agents used and recognized by the classic triad of fever, neutropenia, and abdominal pain, secondary to gastrointestinal injuries that alters mucosal permeability and helps intramural bacterial invasion. ECN is truly a clinical challenge that requires an early diagnosis and a multidisciplinary approach including basic laboratory and imagological tests in high complexity centers. We present a current review, adding epidemiological aspects, risks factors, diagnostic support elements, therapeutic considerations, and preventive measures in order to provide knowledge of this disease and help to reduce morbidity and mortality associated with it.